Search by Drug Name or NDC

    NDC 17433-9876-05 ENEMEEZ 283 mg/5mL Details

    ENEMEEZ 283 mg/5mL

    ENEMEEZ is a RECTAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Enemeez LLC DBA Summit Pharmaceuticals. The primary component is DOCUSATE SODIUM.

    Product Information

    NDC 17433-9876
    Product ID 17433-9876_05556741-fe8b-489b-e063-6394a90a5afe
    Associated GPIs 46500010305110
    GCN Sequence Number 068187
    GCN Sequence Number Description docusate sodium ENEMA 283 MG/5ML RECTAL
    HIC3 Q3S
    HIC3 Description LAXATIVES, LOCAL/RECTAL
    GCN 30916
    HICL Sequence Number 001326
    HICL Sequence Number Description DOCUSATE SODIUM
    Brand/Generic Brand
    Proprietary Name ENEMEEZ
    Proprietary Name Suffix n/a
    Non-Proprietary Name DOCUSATE SODIUM
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route RECTAL
    Active Ingredient Strength 283
    Active Ingredient Units mg/5mL
    Substance Name DOCUSATE SODIUM
    Labeler Name Enemeez LLC DBA Summit Pharmaceuticals
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part334
    Listing Certified Through 2024-12-31

    Package

    NDC 17433-9876-05 (17433987605)

    NDC Package Code 17433-9876-5
    Billing NDC 17433987605
    Package 5 TUBE in 1 CONTAINER (17433-9876-5) / 5 mL in 1 TUBE (17433-9876-0)
    Marketing Start Date 2022-01-14
    NDC Exclude Flag N
    Pricing Information N/A